CNTX · Current Report (Form 8-K) · Filed March 13, 2026

Context Therapeutics Inc — 8-K exhibit

exhibit31-contextxcertific.htm

Context Therapeutics Inc on Boardroom Alpha

Document

Exhibit 3.1

CERTIFICATE OF CORRECTION
OF
AMENDED AND RESTATED CERTIFICATE OF INCORPORATION
OF
CONTEXT THERAPEUTICS INC.

1. The name of the corporation is Context Therapeutics Inc. (the “Corporation”).

2. The Amended and Restated Certificate of Incorporation of the Corporation was filed with the Secretary of State of the State of Delaware on October 21, 2021 (the “Amended and Restated Certificate of Incorporation”), and the Amended and Restated Certificate of Incorporation requires correction as permitted by Section 103 of the General Corporation Law of the State of Delaware.

3. The inaccuracy or defect of the Amended and Restated Certificate of Incorporation is as follows: (i) Article V, Section 2 of the Amended and Restated Certificate of Incorporation provides for a full term of three years for directors, which violates Section 211(b) of the General Corporation Law of the State of Delaware and (ii) Article VI, Section 1 of the Amended and Restated Certificate of Incorporation limits removal of directors only for cause, which violates Section 141(k) of the General Corporation Law of the State of Delaware.

4. Article V, Section 2 and Article VI, Section 1 of the Amended and Restated Certificate of Incorporation were declared invalid by the Court of Chancery of the State of Delaware on March 11, 2026 and are hereby removed in their entirety from the Amended and Restated Certificate of Incorporation.

IN WITNESS WHEREOF, the Corporation has caused this Certificate of Correction to be signed by Martin A. Lehr, its Chief Executive Officer, this 11th day of March, 2026.



			By_/s/ Martin A. Lehr___________________
			Martin A. Lehr Chief Executive Officer

Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer